Shuttle Pharmaceuticals Has Been Granted European Patent Number EP3737376 Titled "Selective Histone Deacetylase Inhibitors For The Treatment Of Human Diseases (Including Cancers, Neurological Disorders, And Immunological Disorders)"
Shuttle Pharmicals 已获得欧洲专利号 EP3737376，标题为 “用于治疗人类疾病（包括癌症、神经系统疾病和免疫系统疾病）的选择性组蛋白脱乙酰酶抑制剂”